These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29602736)

  • 1. Current Status of the Relationship Between Metabolic Syndrome and Lower Urinary Tract Symptoms.
    Sebastianelli A; Gacci M
    Eur Urol Focus; 2018 Jan; 4(1):25-27. PubMed ID: 29602736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
    Gacci M; Corona G; Vignozzi L; Salvi M; Serni S; De Nunzio C; Tubaro A; Oelke M; Carini M; Maggi M
    BJU Int; 2015 Jan; 115(1):24-31. PubMed ID: 24602293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Tubaro A; Vignozzi L; Corona G; McVary KT; Kaplan SA; Maggi M; Carini M; Serni S
    BJU Int; 2015 Aug; 116(2):271-7. PubMed ID: 25597623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.
    Russo GI; Castelli T; Urzì D; Privitera S; Fragalà E; La Vignera S; Condorelli RA; Calogero AE; Favilla V; Cimino S; Morgia G
    Aging Male; 2015; 18(4):207-16. PubMed ID: 26171768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower urinary tract symptoms are associated with low levels of serum serotonin, high levels of adiponectin and fasting glucose, and benign prostatic enlargement.
    Haghsheno MA; Mellström D; Peeker R; Hammarsten J; Lorentzon M; Sundh V; Karlsson M; Ohlsson C; Damber JE
    Scand J Urol; 2015 Apr; 49(2):155-61. PubMed ID: 25253423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erectile Dysfunction and Lower Urinary Tract Symptoms.
    De Nunzio C; Roehrborn CG; Andersson KE; McVary KT
    Eur Urol Focus; 2017 Oct; 3(4-5):352-363. PubMed ID: 29191671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms.
    De Nunzio C; Cindolo L; Gacci M; Pellegrini F; Carini M; Lombardo R; Franco G; Tubaro A
    Urology; 2014 Nov; 84(5):1181-7. PubMed ID: 25443931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).
    Russo GI; Regis F; Spatafora P; Frizzi J; Urzì D; Cimino S; Serni S; Carini M; Gacci M; Morgia G
    BJU Int; 2018 May; 121(5):799-804. PubMed ID: 28872764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Mean Platelet Volume: The Role of Metabolic Syndrome.
    Zhao S; Tang J; Shao S; Yan Y
    Urol Int; 2016; 96(4):449-58. PubMed ID: 26745140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign Prostatic Hyperplasia, Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease: Is Metaflammation the Link?
    Russo GI; Cimino S; Castelli T; Favilla V; Gacci M; Carini M; Condorelli RA; La Vignera S; Calogero AE; Motta F; Puzzo L; Caltabiano R; Morgia G
    Prostate; 2016 Dec; 76(16):1528-1535. PubMed ID: 27458062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation.
    Gacci M; Vignozzi L; Sebastianelli A; Salvi M; Giannessi C; De Nunzio C; Tubaro A; Corona G; Rastrelli G; Santi R; Nesi G; Serni S; Carini M; Maggi M
    Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):101-6. PubMed ID: 23165431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome and smoking are associated with persistence of nocturia after transurethral resection of the prostate.
    De Nunzio C; Tema G; Lombardo R; Cicione A; Nacchia A; D'Annunzio S; Sarchi L; Proietti F; Brassetti A; Tubaro A
    Neurourol Urodyn; 2019 Aug; 38(6):1692-1699. PubMed ID: 31107572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms.
    Zhao S; Chen C; Chen Z; Xia M; Tang J; Shao S; Yan Y
    Urol J; 2016 Jun; 13(3):2717-26. PubMed ID: 27351328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Prostate Size Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from the REDUCE Trial.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal AC; Castro-Santamaria R; Freedland SJ
    Eur Urol; 2016 May; 69(5):885-91. PubMed ID: 26724841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of metabolic status on the association of serum vitamin D with hypogonadism and lower urinary tract symptoms/benign prostatic hyperplasia.
    Park SG; Yeo JK; Cho DY; Park MG
    Aging Male; 2018 Mar; 21(1):55-59. PubMed ID: 28414251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.
    Gacci M; Sebastianelli A; Salvi M; De Nunzio C; Vignozzi L; Corona G; Jaeger T; Chini T; Russo GI; Maggi M; Morgia G; Tubaro A; Carini M; Serni S
    BMC Urol; 2017 Apr; 17(1):22. PubMed ID: 28376747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between lower urinary tract symptoms and metabolic syndrome in a Chinese male population.
    Pan JG; Liu M; Zhou X
    J Endocrinol Invest; 2014 Apr; 37(4):339-44. PubMed ID: 24682909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate-to-high cardiovascular risk is associated with increased lower urinary tract storage symptoms in patients with benign prostatic enlargement.
    De Nunzio C; Truscelli G; Presicce F; Bellangino M; Gacci M; Gaudio C; Tubaro A
    Minerva Urol Nefrol; 2018 Jun; 70(3):340-346. PubMed ID: 29478309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.
    Vignozzi L; Gacci M; Maggi M
    Nat Rev Urol; 2016 Feb; 13(2):108-19. PubMed ID: 26754190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.